New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase

Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells

(2015) Stine Hole et al.   BREAST CANCER RESEARCH AND TREATMENT

Thyroid remnant ablation in differentiated thyroid cancer

(2015) Alfredo Campennì et al.   NUCLEAR MEDICINE COMMUNICATIONS

Antioxidants can increase melanoma metastasis in mice

(2015) Kristell Le Gal et al.   Science Translational Medicine

CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis

(2015) Véronique Orian-Rousseau   Frontiers in Immunology

Deregulated Expression of Aurora Kinases Is Not a Prognostic Biomarker in Papillary Thyroid Cancer Patients

(2015) Enke Baldini et al.   PLoS One

Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines

(2014) E. Baldini et al.   ENDOCRINE-RELATED CANCER

Quercetin inhibits AMPK/TXNIP activation and reduces inflammatory lesions to improve insulin signaling defect in the hypothalamus of high fructose-fed rats

(2014) Qing-Yu Zhang et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention

(2013) Ansgar Bruning   Anti-Cancer Agents in Medicinal Chemistry

Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors

(2013) Shanthi Ganesh et al.   BIOMATERIALS

Stimulation of TLR4 by LMW-HA Induces Metastasis in Human Papillary Thyroid Carcinoma through CXCR7

(2013) Shipeng Dang et al.   Clinical & Developmental Immunology

Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: Is There a Correlation?

(2013) Bojana Jankovic et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cabozantinib in Progressive Medullary Thyroid Cancer

(2013) Rossella Elisei et al.   JOURNAL OF CLINICAL ONCOLOGY

Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model

(2013) F. Rosso et al.   JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

HA-Coated Chitosan Nanoparticles for CD44-Mediated Nucleic Acid Delivery

(2013) Abdulaziz Almalik et al.   MACROMOLECULAR BIOSCIENCE

New Targeted Therapies for Anaplastic Thyroid Cancer

(2012) Alessandro Antonelli et al.   Anti-Cancer Agents in Medicinal Chemistry

Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cells

(2012) Maelinda Daker et al.   Cancer Cell International

Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

(2012) J. C. Arthur et al.   SCIENCE

Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT

(2011) Enke Baldini et al.   BMC CANCER

Bioprotective properties of Dragon's blood resin: In vitro evaluation of antioxidant activity and antimicrobial activity

(2011) Deepika Gupta et al.   BMC Complementary and Alternative Medicine

Quercetin Inhibits IL-1β-Induced Inflammation, Hyaluronan Production and Adipogenesis in Orbital Fibroblasts from Graves' Orbitopathy

(2011) Jin Sook Yoon et al.   PLoS One

Nanostructured hyaluronic acid-based materials for active delivery to cancer

(2010) Dmitri A Ossipov   Expert Opinion on Drug Delivery

Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?

(2010) A. A. Dar et al.   MOLECULAR CANCER THERAPEUTICS

SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo

(2009) Jennifer P. Arbitrario et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY